Trial Profile
Evaluation of the efficacy and safety of subcutaneous administration of CIGB-814 in combination with methotrexate in patients with rheumatoid arthritis.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2020
Price :
$35
*
At a glance
- Drugs CIGB 814 (Primary) ; Folic acid; Methotrexate; Prednisone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 07 Feb 2017 New trial record